Clinical Trials

Clinical trials are both a treatment option for all types of patients and the core way that new advances are made in myeloma care. Learn more about these clinical trials.

Recent Articles

MSK’s Clinical Trial: Reversing CAR T-cell Exhaustion with Antioxidants

May 31, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.

Personalizing CLL Treatments

May 21, 2023

Researchers in Norway used medicine sensitivity screening tests to find the most effective treatment for a relapsed/refractory CLL patient. They found success..

Improving CAR T for CLL with On/Off Switch Molecule

April 27, 2023

One of the current recruiting clinical trials for CLL involves CAR T-cells plus an antibody-based on/off “switch” molecule. The goal of combining these two...

Clinical Trials for CLL: AVO Study

April 26, 2023

The AVO study is reviewing if using a fixed treatment duration of acalabrutinib, venetoclax, and obinutuzumab can help CLL patients achieve a timely and deep...

CLL Recruiting Clinical Trials: MAJIC Study Acalabrutinib + Venetoclax

April 10, 2023

One of the current recruiting clinical trials for CLL is the MAJIC study. Its goal is to find the best venetoclax treatment combination by reviewing which...

CAR T for CLL - TRANSCEND Trial Update

April 09, 2023

The TRANSCEND study provided updates about the effectiveness and safety of CAR T-cell therapy liso-cell for the treatment of CLL….

Successful Results for Pirtobrutinib in Previously Treated CLL Patients

January 01, 2023

Updated data from the Phase I/2 BRUIN study has shown a favorable response of pirtobrutinib in pretreated CLL patients. Pirtobrutinib is a highly potent BTK...